Gordon J. Harris, PhD
Dr. Harris is Co-Director of the Tumor Imaging Metrics Core, Director of the 3D Imaging Service and the Radiology Computer Aided Diagnostics Laboratory (RAD CADx LAB) at the Massachusetts General Hospital (MGH), and Associate Professor of Radiology at Harvard Medical School (HMS). He received his PhD from Johns Hopkins Medical Institutions in Radiation Health Sciences and a BS in Electrical Engineering from Lafayette College. After graduate school, Dr. Harris spent one post-doctoral year and two years as a junior faculty member at Johns Hopkins School of Medicine. He then spent four years as Director of the Neuroimaging Research Laboratory at New England Medical Center, then joined the faculty at MGH in 1997 and began a new 3D Imaging Service for clinically-oriented imaging. Dr. Harris' primary research interests include structural and functional brain imaging research in psychiatric and neurologic illnesses, including stroke and alcoholism, as well as quantitative tracking of tumors for clinical care and clinical trials. Dr. Harris has published and lectured extensively on medical imaging.
Annick D. Van den Abbeele, MD
Dr. Van den Abbeele is Co-Director of the Tumor Imaging Metrics Core, Chief of the Department of Imaging and Founding Director of the Center for Biomedical Imaging in Oncology (CBIO) at the Dana-Farber Cancer Institute (DFCI), and an Associate Professor of Radiology at Harvard Medical School. Dr. Van den Abbeele received her BA and MD from the University of Louvain in Belgium. Following a residency in Pediatrics at the University of Louvain and a Neonatology fellowship at Vanderbilt University Medical Center in Nashville, TN, she completed a residency in Nuclear Medicine and a fellowship in Radiology at the Brigham and Women's Hospital (BWH), Boston, MA and Harvard Medical School. She has been a faculty member of the Department of Radiology at the BWH and HMS since 1987. Dr. Van den Abbeele is nationally and internationally known for her work in molecular imaging building upon her pioneering work in monitoring response to targeted therapy in gastrointestinal stromal tumors. She is also a leader in developing novel applications and quantitative metrics in cancer imaging. She serves on several national committees, has received several awards, has authored more than 200 scientific articles and abstracts, edited two textbooks, authored 19 chapters, and presented numerous lectures and workshops nationally and internationally.